Molecular mechanisms linking adipokines to obesity-related colon cancer: Focus on leptin

Proceedings of the Nutrition Society

Volumn 71, Issue 1, 2012, Pages 175-180

  Drew, Janice E ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Adipokine; Adipose; Colon cancer; Cytokine; Leptin

Indexed keywords

ADIPOCYTOKINE; LEPTIN; LEPTIN RECEPTOR;

ADIPOSE TISSUE; BODY WEIGHT; CANCER GROWTH; CANCER MODEL; CANCER RISK; COLON CANCER; CONFERENCE PAPER; DISEASE ASSOCIATION; GENOTYPE; HORMONE RELEASE; HUMAN; INFLAMMATION; MEDIATOR RELEASE; MOLECULAR DYNAMICS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; COLON; COLONIC NEOPLASMS; HUMANS; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; LEPTIN; OBESITY; RECEPTORS, LEPTIN;

RODENTIA;

EID: 84856241235     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665111003259     Document Type: Conference Paper

References (71)

1. WHO (2007) European Action Plan for Food and Nutrition Policy 2007-2012. Copenhagen: WHO Regional Office for Europe.
2. WHO (2008) Obesity and Overweight. WHO Fact Sheet No. 311. http://www.who.int/mediacentre/factsheets/fs311/en/index.html
3. Guh DP, Zhang W, Bansback N et al. (2009) The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 9, 88.
4. Calle EE & Kaaks R (2004) Overweight obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4, 579-591. (Pubitemid 39025053)
5. Harriss DJ, Atkinson G, George K et al. (2009) Lifestyle factors and colorectal cancer risk: Systematic review and meta-analysis of associations with body mass index. Colorectal Dis 11, 689-701.
6. Giovannucci E, Ascherio A, Rimm EB et al. (1995) Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Int Med 122, 327-334.
7. Le Marchand L, Wilkins LR, Kolonel LN et al. (1997) Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 57, 4787-4794. (Pubitemid 27468985)
8. Frezza EE, Wachtel MS & Chiriva-Internati M (2006) The influence of obesity on the risk of developing colon cancer. Gut 55, 285-291. (Pubitemid 43117290)
9. World Cancer Research Fund/American Institute for Cancer Research (2007) Food Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR.
10. World Cancer Research Fund/American Institute for Cancer Research WCRF/AICR (2010) Systematic Literature Review Continuous Update Project Report. The Associations between Food, Nutrition and Physical Activity and the Risk of Colorectal Cancer.
11. Potter JD (1999) Colorectal cancer: Molecules and populations. J Natl Cancer Inst 91, 916-932. (Pubitemid 29272518)
12. Kershaw EE & Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89, 2548-2556. (Pubitemid 38766330)
13. Ostlund RE Jr, Yang JW, Klein S et al. (1996) Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 81, 3909-3913. (Pubitemid 26380395)
14. Fatouros IG, Tournis S, Leontsini D et al. (2005) Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related. J Clin Endocrinol Metab 90, 5970-5977. (Pubitemid 41606513)
15. Al-Lahham SH, Roelofsen H, Priebe M et al. (2010) Regulation of adipokine production in human adipose tissue by propionic acid. Eur J Clin Invest 40, 401-407.
16. Dutheil F, Lesourd B, Courteix D et al. (2010) Blood lipids and adipokines concentrations during a 6-month nutritional and physical activity intervention for metabolic syndrome treatment. Lipids Health Dis 9, 148.
17. Friedman JM & Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395, 763-770. (Pubitemid 28485436)
18. McTiernan A (2005) Obesity and cancer, the risks, science, and potential management strategies. Oncol 19, 871-881. (Pubitemid 41725381)
19. Kelesidis I, Kelesidis T & Mantzoros CS (2006) Adiponectin and cancer: A systematic review. Br J Cancer 94, 1221-1225.
20. Fantuzzi G & Faggioni R (2000) Leptin in regulation of immunity, inflammation and hematopoiesis. J Leukoc Biol 68, 437-436.
21. Abolhassani M, Aloulou N, Chaumett MT et al. (2008) Leptin receptor-related immune response in colorectal tumors: The role of colonocytes and interleukin-8. Cancer Res 68, 9423-9432.
22. Sitaraman S, Liu X, Charrier L et al. (2004) Colonic leptin: Source of a novel pro-inflammatory cytokine involved in inflammatory bowel disease. FASEB J 18, 696-698.
23. Karmiris K, Koutroubakis IE, Xidakis C et al. (2006) Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 12, 100-105.
24. Koda M, Sulkowska M, Kanczuga-Koda L et al. (2007) Overexpression of the obesity hormone leptin in human colon cancer. J Clin Pathol 60, 902-906. (Pubitemid 47234437)
25. Drew JE, Farquharson AJ, Padidar S et al. (2007) Insulin, leptin and adiponectin receptors in colon: Regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine. Am J Physiol Gastrointest Liver Physiol 293, G682-G691. (Pubitemid 47605924)
26. Hardwick JC, Van Den Brink GR, Offerhaus GJ et al. (2001) Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121, 79-90. (Pubitemid 32591517)
27. Ponz de Leon M & Di Gregorio C (2001) Pathology of colorectal cancer. Digest Liver Dis 33, 372-388. (Pubitemid 32537027)
28. Arita Y, Kihara S, Ouchi N et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257, 79-83. (Pubitemid 29299050)
29. Aparicio T, Kotelevets L, Tsocas A et al. (2005) Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice nor intestinal tumourigenesis in ApcMin/+ mice. Gut 54, 1136-1145. (Pubitemid 41025909)
30. Hoda MR, Keely SJ, Bertelsen LS et al. (2007) Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg 94, 346-354. (Pubitemid 46423854)
31. Ogunwobi OO & Beales IL (2007) The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt. Int J Colorectal Dis 22, 401-409. (Pubitemid 46336244)
32. Jaffe T & Schwartz B (2008) Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer 123, 2543-2556.
33. Schnabele K, Roser S, Rechkemmer G et al. (2009) Effects of adipocyte-secreted factors on cell cycle progression in HT29 cells. Eur J Nutr 48, 154-161.
34. Ogunwobi OO & Beales IL (2007) Cyclo-oxygenaseindependent inhibition of apoptosis and stimulation of proliferation by leptin in human colon cancer cells. Dig Dis Sci 52, 1934-1945. (Pubitemid 47024680)
35. Rouet-Benzineb P, Aparicio T, Guilmeau S et al. (2004) Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling. J Biol Chem 279, 16495-16502. (Pubitemid 38509348)
36. Fenton JI, Hursting SD, Perkins SN et al. (2006) Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+ ) colon epithelial cell line. Carcinogenesis 27, 1507-1515. (Pubitemid 43994862)
37. Whitehead RH, VanEeden PE, Noble MD et al. (1993) Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci USA 90, 587-591. (Pubitemid 23028908)
38. Fenton JI, Lavigne JA, Perkins SN et al. (2008) Microarray analysis reveals that leptin induces autocrine/paracrine cascades to promote survival and proliferation of colon epithelial cells in an Apc genotype-dependent fashion. Mol Carcinog 47, 9-21.
39. Fenton JI, Hursting SD, Perkins SN et al. (2007) Leptin induces an Apc genotype-associated colon epithelial cell chemokine production pattern associated with macrophage chemotaxis and activation. Carcinogenesis 28, 455-464. (Pubitemid 46321863)
40. Somasundar P, Yu AK, Vona-Davis L et al. (2003) Differential effects of leptin on cancer in vitro. J Surg Res 113, 50-55. (Pubitemid 36999792)
41. Bartucci M, Svensson S, Ricci-Vitiani L et al. (2010) Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumour stem cells. Endocr Relat Cancer 17, 823-833.
42. Luongo C, Moser AR, Gledhill S et al. (1994) Loss of Apc + in intestinal adenomas from Min mice. Cancer Res 54, 5947-5952. (Pubitemid 24375232)
43. Aparicio T, Guilmeau S, Goiot H et al. (2004) Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat coloni mucosa. Gastroenterology 126, 449-510.
44. Ealey KN, Lu S & Archer MC (2008) Development of aberrant crypt foci in the colons of ob/ob and db/db mice: Evidence that leptin is not a promoter. Mol Carcinog 47, 667-677.
45. Endo H, Hosono K, Uchiyama T et al. (2011) Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 60, 1363-1371 .
46. Liu Z, Uesaka T, Watanabe H et al. (2001) High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int J Oncol 19, 1009-1014.
47. Uchiyama T, Takahashi H, Endo H et al. (2011) Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression. J Oncol 39, 935-940.
48. Teraoka N, Mutoh M, Takasu S et al. (2011) High susceptibility to azoxymethane-induced colorectal carcinogenesis in obese KK-Ay mice. Int J Cancer 129, 528-535.
49. Sohn OS, Fiala ES, Requeijo SP et al. (2001) Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol. Cancer Res 61, 8435-8440. (Pubitemid 33131121)
50. Suzuki R, Kohno H, Sugie S et al. (2006) Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis 27, 162-169. (Pubitemid 43025257)
51. Padidar S, Farquharson AJ, Williams LM et al. (2011) Impact of obesity and leptin on protein expression profiles in mouse colon. Digest Dis Sci 56, 1028-1036.
52. Padidar S, Farquharson AJ, Williams LM et al. (2011) Leptin upregulates pro-inflammatory cytokines in discrete cells within mouse colon. J Cell Physiol 226, 2123-2130.
53. Atreya R & Neurath MF (2005) Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol B, 00, 187-196.
54. Rose-John S, Mitsuyama K, Matsumoto S et al. (2009) Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease. Curr Pharm Des 15, 2095-2103.
55. Park EJ, Lee JH, Yu G-Y et al. (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197-208.
56. Drew JE, Mayer C-D, Farquharson AJ et al. (2011) Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in colon normal, polyp and tumour tissue. J Mol Diag 13, 233-242.
57. Yang SK, Eckmann L, Panja A et al. (1997) Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 113, 1214-1223. (Pubitemid 27418975)
58. Birmingham JM, Busik JV, Hansen-Smith FM et al. (2009) Novel mechanism for obesity-induced colon cancer progression. Carcinogenesis 30, 690-697.
59. Aloulou N, Bastuji-Garin S, Le Gouvello S et al. (2008) Involvement of the leptin receptor in the immune response in intestinal cancer. Cancer Res 68, 9413-9422.
60. Uddin S, Bavi P, Hussain AR et al. (2009) Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Carcinogenesis 30, 1832-1840.
61. Stachowicz M, Mazurek U, Nowakowska-Zajdel E et al. (2010) Leptin and its receptors in obese patients with colorectal cancer. J Biol Regul Homeost Agents 24, 287-295.
62. Paik SS, Jang SM, Jang KS et al. (2009) Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Ann Surg Oncol 16, 297-303.
63. Stattin P, Lukanova A, Biessy C et al. (2004) Obesity and colon cancer: Does leptin provide a link? Int J Cancer 109, 149-152. (Pubitemid 38160676)
64. Stattin P, Palmqvist R, Söderberg S et al. (2003) Plasma leptin and colorectal cancer risk: A prospective study in Northern Sweden. Oncol Rep 10, 2015-2021.
65. Bolukbas FF, Kilic H, Bolukbas C et al. (2004) Serum leptin concentration and advanced gastrointestinal cancers: A case controlled study. BMC Cancer 4, 29.
66. Kumor A, Daniel P, Pietruczuk M et al. (2009) Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 24, 275-281.
67. Salageanu A, Tucureanu C, Lerescu L et al. (2010) Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life 3, 416-420.
68. Donnelly S & Walsh TD (1995) The symptoms of advanced cancer. Semin Oncol 22, Suppl. 3, 67-72.
69. Arpaci F, Yilmaz MI, Ozet A et al. (2002) Low serum leptin level in colon cancer patients without significant weight loss. Tumori 88, 147-149. (Pubitemid 34602188)
70. Moses AG, Dowidar N, Holloway B et al. (2001) Leptin and its relation to weight loss, ob gene expression and the acutephase response in surgical patients. Br J Surg 88, 588-593. (Pubitemid 32291243)
71. Anderson AS & Caswell S (2009) Obesity management-an opportunity for cancer prevention. Surgeon 7, 282-285.